Estimation of liver fibrosis by noncommercial serum markers in comparison with transient elastography in patients with chronic hepatitis C virus infection receiving direct-acting antiviral treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Estimation of liver fibrosis by noncommercial serum markers in comparison with transient elastography in patients with chronic hepatitis C virus infection receiving direct-acting antiviral treatment

Published:2018-11-08 Issue:2 Volume:26 Page:224-230
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Knop Viola¹^ORCID,Hofmann Wolf P.²,Buggisch Peter³,Klinker Hartwig⁴,Mauss Stefan⁵,Günther Rainer⁶,Hinrichsen Holger⁷,Hüppe Dietrich⁸,Pfeiffer-Vornkahl Heike⁹,Simon Karl-Georg¹⁰,Berg Thomas¹¹,Manns Michael P.¹²,Friedrich-Rust Mireen¹,

Affiliation:

1. Department of Internal Medicine 1; Goethe University Hospital; Frankfurt Germany

2. Gastro Study Center, Berlin; Berlin Germany

3. ifi-institute for interdisciplinary medicine; Hamburg Germany

4. University Hospital Würzburg; Würzburg Germany

5. Center for HIV and Hepatogastroenterology; Düsseldorf Germany

6. Universitätsklinikum Schleswig-Holstein; Kiel Germany

7. Gastroenterology-Hepatology Center Kiel; Kiel Germany

8. Hepatologische Schwerpunktpraxis Herne; Herne Germany

9. e.factum GmbH; Butzbach Germany

10. Hepatologische Praxis; Leverkusen Germany

11. University Hospital Leipzig; Leipzig Germany

12. Hannover Medical School; Hannover Germany

Funder

Bristol-Myers Squibb GmbH & Co.

AbbVie Deutschland

Janssen-Cilag GmbH

Roche Pharma AG

MSD Sharp & Dohme GmbH

Gilead Sciences GmbH

Deutsches Zentrum für Infektionsforschung

Dohme GmbH

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jvh.13021/fullpdf

Reference33 articles.

1. Hepatitis C virus infection;Lauer;N Engl J Med,2001

2. Epidemiology and natural history of HCV infection;Hajarizadeh;Nat Rev Gastroenterol Hepatol,2013

3. Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis;Meer;JAMA,2012

4. Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: lessons from the HALT-C trial;Everson;Hepatology,2006

5. HCV targeting of patients with cirrhosis;Ferenci;J Hepatol,2015

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Test characteristics for combining non‐invasive liver fibrosis staging modalities in individuals with Hepatitis C virus;Journal of Viral Hepatitis;2024-02-07

2. Evaluation of Direct-Acting Antiviral Therapy Efficacy and Post-Treatment Fibrosis with Noninvasive Markers in Patients with Chronic Hepatitis C;Flora the Journal of Infectious Diseases and Clinical Microbiology;2023-12-22

3. FibroMeter scores are predictive noninvasive markers of advanced and significant liver fibrosis in patients with chronic viral hepatitis or metabolic dysfunction-associated steatotic liver disease;Annals of Gastroenterology;2023

4. An Evaluation of Chronic Hepatitis C Patients’ Responses to Direct-Acting Antivirals According to Transient Elastography and Serum Biomarkers;Viral Hepatitis Journal;2022-04-01

5. Effect of Direct-Acting Antiviral Therapy on Thrombocytopenic Patients with Hepatitis C Virus-Related Chronic Liver Disease;Gastroenterology Research and Practice;2021-05-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3